Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Cambridge

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Annals of the Rheumatic Diseases|October 27, 2007
B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical responseG Cambridge, D A Isenberg, J C W Edwards, et al.
Digestive Diseases and Sciences|March 1, 1993
Anti-endothelial cell antibodies in inflammatory bowel diseaseT R Stevens, S L Harley, J S Groom, et al.
Clinical and Experimental Immunology|October 24, 2014
Effect of rituximab on B cell phenotype and serum B cell-activating factor levels in patients with thrombotic thrombocytopenic purpuraE Becerra, M A Scully, M J Leandro, et al.
Lancet (London, England)|May 13, 1989
Cyclosporin in juvenile dermatomyositisJ Heckmatt, N Hasson, C Saunders, et al.
Annals of the New York Academy of Sciences|November 27, 1995
The immune response to HIV gp120 induced by nucleic acid immunization (NAI)N Peet, P J Delves, B de Souza, et al.
Immunology|February 1, 1996
Analysis of immunoglobulin variable region genes of a human IgM anti-myeloperoxidase antibody derived from a patient with vasculitisC Longhurst, M R Ehrenstein, B Leaker, et al.
Autoimmunity|January 1, 1992
Analysis of antibody reactivity in the sera of 42 patients with paraproteinaemiaA J MacGregor, J Kalsi, C T Ravirajan, et al.
Journal of Autoimmunity|December 25, 2013
The effect of B-cell depletion therapy on serological evidence of B-cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatmentG Cambridge, H C Perry, L Nogueira, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Annals of the Rheumatic Diseases|October 27, 2007
B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical responseG Cambridge, D A Isenberg, J C W Edwards, et al.
Digestive Diseases and Sciences|March 1, 1993
Anti-endothelial cell antibodies in inflammatory bowel diseaseT R Stevens, S L Harley, J S Groom, et al.
Clinical and Experimental Immunology|October 24, 2014
Effect of rituximab on B cell phenotype and serum B cell-activating factor levels in patients with thrombotic thrombocytopenic purpuraE Becerra, M A Scully, M J Leandro, et al.
Lancet (London, England)|May 13, 1989
Cyclosporin in juvenile dermatomyositisJ Heckmatt, N Hasson, C Saunders, et al.
Annals of the New York Academy of Sciences|November 27, 1995
The immune response to HIV gp120 induced by nucleic acid immunization (NAI)N Peet, P J Delves, B de Souza, et al.
Immunology|February 1, 1996
Analysis of immunoglobulin variable region genes of a human IgM anti-myeloperoxidase antibody derived from a patient with vasculitisC Longhurst, M R Ehrenstein, B Leaker, et al.
Autoimmunity|January 1, 1992
Analysis of antibody reactivity in the sera of 42 patients with paraproteinaemiaA J MacGregor, J Kalsi, C T Ravirajan, et al.
Journal of Autoimmunity|December 25, 2013
The effect of B-cell depletion therapy on serological evidence of B-cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatmentG Cambridge, H C Perry, L Nogueira, et al.
Pageof 7